Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/23/2012US20120046348 Oligonucleotide chelate complexes
02/23/2012US20120046345 Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family
02/23/2012US20120046344 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
02/23/2012US20120046343 MULTI-TARGETING SHORT INTERFERING RNAs
02/23/2012US20120046342 Oligonucleotide comprising an inosine for treating dmd
02/23/2012US20120046341 Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseases
02/23/2012US20120046340 Down Regulation of the Gene Expression by Means of Nucleic Acid-Loaded Virus-Like Particles
02/23/2012US20120046338 Fused cyclic compounds
02/23/2012US20120046337 Novel Five-Membered Iminocyclitol Derivatives as Selective and Potent Glycosidase Inhibitors: New Structures for Antivirals and Osteoarthritis Therapeutics
02/23/2012US20120046336 Methods and compositions for improving cognitive function
02/23/2012US20120046335 Solid states of atorvastatin potassium
02/23/2012US20120046334 Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
02/23/2012US20120046333 Methods and Compositions of PI-3 Kinase Inhibitors for Treating Fibrosis
02/23/2012US20120046332 Compositions and methods for treating corneal haze
02/23/2012US20120046331 Antifungal Agents and Uses Thereof
02/23/2012US20120046330 Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
02/23/2012US20120046329 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof
02/23/2012US20120046327 Method for inhibiting the induction and formation of osteoclasts
02/23/2012US20120046326 Drug containing benzophenone derivative or its salt
02/23/2012US20120046325 Isoxazoline Compounds Having MIF Antagonist Activity
02/23/2012US20120046324 Small molecule inhibitors of kynurenine-3-monooxygenase
02/23/2012US20120046322 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
02/23/2012US20120046321 Methods of treating atrial fibrillation with p38 inhibitor compounds
02/23/2012US20120046320 Beta- and gamma-diketones and gamma-hydroxyketones as wnt/beta-catenin signaling pathway activators
02/23/2012US20120046319 Process for the preparation of enantiomerically enriched proton pump inhibitors
02/23/2012US20120046318 Methods and compositions for treating internal and external hemorrhoids
02/23/2012US20120046317 Novel heterocyclic compounds
02/23/2012US20120046316 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/23/2012US20120046315 Intermediate and oral administrative formats containing lenalidomide
02/23/2012US20120046314 Nitroxides for use in treating or preventing neoplastic disease
02/23/2012US20120046313 Siloxane polymer containing tethered fluoroquinolone
02/23/2012US20120046312 3-substituted propanamine compounds
02/23/2012US20120046311 Chemokine receptor antagonists and methods of use thereof
02/23/2012US20120046310 Compositions for delivering highly water soluble drugs
02/23/2012US20120046309 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
02/23/2012US20120046308 Novel alpha-phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same
02/23/2012US20120046307 Allosteric protein kinase modulators
02/23/2012US20120046306 Substituted Heteroaryl Spiropyrrolidine MDM2 Antagonists
02/23/2012US20120046305 Methods and compositions for treating respiratory disorders
02/23/2012US20120046304 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
02/23/2012US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors
02/23/2012US20120046302 Methods of treating cns disorders
02/23/2012US20120046301 Substituted Cyclic Carboxamide and Urea Derivatives as Ligands of the Vanilloid Receptor
02/23/2012US20120046300 Quinazoline Derivatives as Angiogenesis Inhibitors
02/23/2012US20120046299 Method of treating arrhythmias
02/23/2012US20120046298 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
02/23/2012US20120046297 Crystalization of pharmaceutical compounds
02/23/2012US20120046296 Palatable ductile chewable veterinary composition
02/23/2012US20120046295 Compounds useful as inhibitors of atr kinase
02/23/2012US20120046294 Compounds for the Treatment of Hepatitis C
02/23/2012US20120046293 Renin inhibitors
02/23/2012US20120046292 Diacylethylenediamine compound
02/23/2012US20120046291 Extended Triterpene Derivatives
02/23/2012US20120046290 Inhibition of p38 kinase activity using substituted heterocyclic ureas
02/23/2012US20120046289 Pyridazine Carboxamide Orexin Receptor Antagonists
02/23/2012US20120046288 Hydrazonamide Compounds That Modulate Hsp90 Activity
02/23/2012US20120046287 Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
02/23/2012US20120046286 Novel Compounds
02/23/2012US20120046285 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
02/23/2012US20120046284 Salts and hydrates of 4-[(3-chloro-4-fluoro-phenyl)amino]-6-(cis-4--cyclohexan-1-yloxy)-7-methoxy-quinazoline, their use as a medicament and the preparation thereof
02/23/2012US20120046283 Compounds for treating neuropsychiatric conditions
02/23/2012US20120046282 Methods and compounds for antimicrobial intervention
02/23/2012US20120046281 Rifalazil compositions and therapeutic regimens
02/23/2012US20120046280 Novel heteropyrrole analogs acting on cannabinoid receptors
02/23/2012US20120046279 Oligomer-Phenothiazine Conjugates
02/23/2012US20120046278 Thiazolopyrimidine modulators as immunosuppressive agents
02/23/2012US20120046277 Benzofuran derivatives
02/23/2012US20120046276 Tuberculosis treatment using pleuromutilin derivatives
02/23/2012US20120046275 Cytoskeletal active rho kinase inhibitor compounds, composition and use
02/23/2012US20120046274 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
02/23/2012US20120046273 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
02/23/2012US20120046272 Novel Therapeutic Compounds
02/23/2012US20120046271 2,5-Methano- and 2,5-Ethano-Tetrahydrobenzazepine Derivatives And Use Thereof To Block Reuptake Of Norepinephrine, Dopamine, and Serotonin
02/23/2012US20120046270 Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases
02/23/2012US20120046269 Novel Amino Azaheterocyclic Carboxamides
02/23/2012US20120046268 Substituted piperidines as Par-1 Antagonists
02/23/2012US20120046267 7-aminofuropyridine derivatives
02/23/2012US20120046266 Resorcinol derivatives as hsp90 inhibitors
02/23/2012US20120046265 USE OF ERGOSTA-7,22-DIEN-3beta-OL IN THE TREATMENT OF CANCER
02/23/2012US20120046264 Commercial scale production methods for transdermal hormone formulations
02/23/2012US20120046263 Method to alter sex ratios in avian offspring
02/23/2012US20120046262 Megestrol acetate products, method of manufacture, and method of use
02/23/2012US20120046261 Compositions and methods for diagnosing and preventing spontaneous preterm birth
02/23/2012US20120046260 Methods and Devices for Delivery of Compositions to Conduits
02/23/2012US20120046259 Composition comprising an antibiotic and a corticosteroid
02/23/2012US20120046258 Novel crystalline pharmaceutical product
02/23/2012US20120046257 Methods for Administration and Formulations for the Treatment of Regional Adipose Tissue
02/23/2012US20120046256 Lipolytic Methods for Regional Adiposity Comprising Salmeterol or Formoterol
02/23/2012US20120046255 Non-steroidal compounds
02/23/2012US20120046254 Dispersion of phytosterols
02/23/2012US20120046253 STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY
02/23/2012US20120046252 Calcium Formate for Use as a Dietary Supplement
02/23/2012US20120046251 Inhibitors of soluble epoxide hydrolase to inhibit or prevent niacin-induced flushing
02/23/2012US20120046250 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell
02/23/2012US20120046249 Methods of reducing the risk of cardiovascular disease in postmenopausal women
02/23/2012US20120046247 1,5-diphenyl-penta-1,4-dien-3-one compounds
02/23/2012US20120046246 Methods for treating osteoclast-related disease, compounds and compositions thereof
02/23/2012US20120046245 Compositions and methods for inhibition of the jak pathway
02/23/2012US20120046244 Dual functioning ionic liquids and salts thereof
02/23/2012US20120046243 Aminopyridine- and Aminopyrimidinecarboxamides as CXCR2 Modulators
1 ... 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 ... 7860